Quick links
Select
Contact Us
Fact Sheet
Discovery Pipeline
Download Center
Annual Reports
Company Profiles
Job Opportunities
Press Releases
> MEDIA
Overview
Press Releases
Media Stories
Download Center
Video Gallery
Photo Gallery
Media Contacts
Press Releases
2017
2018
2019
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
November 2014
03 Nov
Biocon Expands its Strategic Partnership
with CytoSorbents for CytoSorb
®
to Treat
SIRS and Cardiac Surgery Patients
October 2014
21 Oct
Biocon Q2 FY15 Revenues at Rs 773 Crore,
PAT at Rs 102 Crore; Branded
Formulations Records Strong Growth
of 17%
September 2014
18 Sep
Silver Leaf Oak acquires 10% stake in
Syngene International, Biocon's Research
Services Subsidiary
01 Sep
Biocon Kick-Starts Free Oral Cancer
Screening Programs Across India
August 2014
10 Aug
Biocon to Mark a Decade of Excellence in
Affordable Insulin Therapy
06 Aug
Biocon Foundation Receives 'Asia Best CSR
Practices Award 2014' for 'Cervical Cancer
Screening Program'
July 2014
24 Jul
Biocon announces Q1 FY15 results; Revenues: Rs 742 Crs; EBITDA:
Rs 191 Crs; PAT: Rs 103 Crs
June 2014
23 Jun
Kiran Mazumdar-Shaw Awarded the
'2014 Global Economy Prize' by the
Kiel Institute for the World Economy
03 Jun
Bristol-Myers Squibb and Syngene
International Extend Research
Collaboration
May 2014
16 May
Kiran Mazumdar-Shaw Receives Coveted
'Othmer Gold Medal 2014' from Chemical
Heritage Foundation
April 2014
24 Apr
Broad-based business momentum helps Biocon deliver 16% revenue growth in
FY14, Board recommends a dividend of
Rs 5/share (100%)
24 Apr
Dr. Arun Chandavarkar Appointed as CEO
and Joint Managing Director of Biocon Ltd
February 2014
05 Feb
Shri Ghulam Nabi Azad Inaugurates Baxter
Global Research Center at Syngene
January 2014
22 Jan
Biocon delivers 16% growth led by
Research Services & Branded Formulations
22 Jan
Biocon Collaborates with Advaxis for
'ADXS-HPV'A Novel Cancer
Immunotherapy
22 Jan
Kiran Mazumdar-Shaw to Receive 2014
Othmer Gold Medal from Chemical
Heritage Foundation
18 Jan
Biocon introduces CANMAb
™
-
Trastuzumab for Treating Breast Cancer
in India
10 Jan
Biocon Academy's Flagship Program in
Collaboration with KGI Takes Off to a
Flying Start
Biocon
Businesses
Recommended sites
Biocon on
Home
About Us
Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program
ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy
Report adverse event/side effects and product complaints
* Disclaimer
© 2018, Biocon. All Rights Reserved